These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 31549414)

  • 61. A sensitive and rapid alternative to HLA typing as a genetic screening test for abacavir hypersensitivity syndrome.
    Martin AM; Krueger R; Almeida CA; Nolan D; Phillips E; Mallal S
    Pharmacogenet Genomics; 2006 May; 16(5):353-7. PubMed ID: 16609367
    [TBL] [Abstract][Full Text] [Related]  

  • 62. New genetic predictors for abacavir tolerance in HLA-B*57:01 positive individuals.
    Pavlos R; Deshpande P; Chopra A; Leary S; Strautins K; Nolan D; Thorborn D; Shaefer M; Rauch A; Dunn D; Montaner J; Rachlis A; Almeida CA; Choo L; James I; Redwood AJ; Li Y; Gaudieri S; Mallal SA; Phillips EJ
    Hum Immunol; 2020 Jun; 81(6):300-304. PubMed ID: 32173028
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Immune responses to abacavir in antigen-presenting cells from hypersensitive patients.
    Martin AM; Almeida CA; Cameron P; Purcell AW; Nolan D; James I; McCluskey J; Phillips E; Landay A; Mallal S
    AIDS; 2007 Jun; 21(10):1233-44. PubMed ID: 17545699
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Use of the HCP5 single nucleotide polymorphism to predict hypersensitivity reactions to abacavir: correlation with HLA-B*5701.
    Rodríguez-Nóvoa S; Cuenca L; Morello J; Córdoba M; Blanco F; Jiménez-Nácher I; Soriano V
    J Antimicrob Chemother; 2010 Aug; 65(8):1567-9. PubMed ID: 20534626
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The use of HLA-A*0201-transfected K562 as standard antigen-presenting cells for CD8(+) T lymphocytes in IFN-gamma ELISPOT assays.
    Britten CM; Meyer RG; Kreer T; Drexler I; Wölfel T; Herr W
    J Immunol Methods; 2002 Jan; 259(1-2):95-110. PubMed ID: 11730845
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Association of HLA-B*5701 genotypes and abacavir-induced hypersensitivity reaction: a systematic review and meta-analysis.
    Tangamornsuksan W; Lohitnavy O; Kongkaew C; Chaiyakunapruk N; Reisfeld B; Scholfield NC; Lohitnavy M
    J Pharm Pharm Sci; 2015; 18(1):68-76. PubMed ID: 25877443
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Oxypurinol directly and immediately activates the drug-specific T cells via the preferential use of HLA-B*58:01.
    Yun J; Marcaida MJ; Eriksson KK; Jamin H; Fontana S; Pichler WJ; Yerly D
    J Immunol; 2014 Apr; 192(7):2984-93. PubMed ID: 24591375
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The frequency of HLA-B(∗)57:01 and the risk of abacavir hypersensitivity reactions in the majority population of Costa Rica.
    Arrieta-Bolaños E; Madrigal JA; Marsh SG; Shaw BE; Salazar-Sánchez L
    Hum Immunol; 2014 Nov; 75(11):1092-6. PubMed ID: 25286002
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Clinical pharmacogenetics implementation consortium guidelines for HLA-B genotype and abacavir dosing.
    Martin MA; Klein TE; Dong BJ; Pirmohamed M; Haas DW; Kroetz DL;
    Clin Pharmacol Ther; 2012 Apr; 91(4):734-8. PubMed ID: 22378157
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Association of the genetic marker for abacavir hypersensitivity HLA-B*5701 with HCP5 rs2395029 in Mexican Mestizos.
    Sanchez-Giron F; Villegas-Torres B; Jaramillo-Villafuerte K; Silva-Zolezzi I; Fernandez-Lopez JC; Jimenez-Sanchez G; Carnevale A
    Pharmacogenomics; 2011 Jun; 12(6):809-14. PubMed ID: 21510768
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Immunodominant tuberculosis CD8 antigens preferentially restricted by HLA-B.
    Lewinsohn DA; Winata E; Swarbrick GM; Tanner KE; Cook MS; Null MD; Cansler ME; Sette A; Sidney J; Lewinsohn DM
    PLoS Pathog; 2007 Sep; 3(9):1240-9. PubMed ID: 17892322
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Prospective validation of a pharmacogenetic test: the PREDICT-1 study].
    Muñoz de Benito RM; Arribas López JR
    Enferm Infecc Microbiol Clin; 2008 May; 26 Suppl 6():40-4. PubMed ID: 18680695
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Abacavir Hypersensitivity Reaction Reporting Rates During a Decade of HLA-B*5701 Screening as a Risk-Mitigation Measure.
    Stainsby CM; Perger TM; Vannappagari V; Mounzer KC; Hsu RK; Henegar CE; Oyee J; Urbaityte R; Lane CE; Carter LM; Pakes GE; Shaefer MS
    Pharmacotherapy; 2019 Jan; 39(1):40-54. PubMed ID: 30414209
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Identification and characterisation of peptide binding motifs of six autoimmune disease-associated human leukocyte antigen-class I molecules including HLA-B*39:06.
    Eichmann M; de Ru A; van Veelen PA; Peakman M; Kronenberg-Versteeg D
    Tissue Antigens; 2014 Oct; 84(4):378-88. PubMed ID: 25154780
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Alterations in the HLA-B*57:01 Immunopeptidome by Flucloxacillin and Immunogenicity of Drug-Haptenated Peptides.
    Puig M; Ananthula S; Venna R; Kumar Polumuri S; Mattson E; Walker LM; Cardone M; Takahashi M; Su S; Boyd LF; Natarajan K; Abdoulaeva G; Wu WW; Roderiquez G; Hildebrand WH; Beaucage SL; Li Z; Margulies DH; Norcross MA
    Front Immunol; 2020; 11():629399. PubMed ID: 33633747
    [TBL] [Abstract][Full Text] [Related]  

  • 76. High Frequency of Human Leukocyte Antigen-B*57:01 Allele Carriers among HIV-Infected Patients in Serbia.
    Siljic M; Salemovic D; Cirkovic V; Pesic-Pavlovic I; Todorovic M; Ranin J; Dragovic G; Jevtovic D; Stanojevic M
    Intervirology; 2017; 60(1-2):43-47. PubMed ID: 28772259
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Genetic variations in HLA-B region and hypersensitivity reactions to abacavir.
    Hetherington S; Hughes AR; Mosteller M; Shortino D; Baker KL; Spreen W; Lai E; Davies K; Handley A; Dow DJ; Fling ME; Stocum M; Bowman C; Thurmond LM; Roses AD
    Lancet; 2002 Mar; 359(9312):1121-2. PubMed ID: 11943262
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Human leukocyte antigens and drug hypersensitivity.
    Chung WH; Hung SI; Chen YT
    Curr Opin Allergy Clin Immunol; 2007 Aug; 7(4):317-23. PubMed ID: 17620823
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Functional supertype of HLA-A2 in the presentation of Flu matrix p58-66 to induce CD8+ T-cell response in a Northern Chinese population.
    Zhang HG; Pang XW; Shang XY; Xing Q; Chen WF
    Tissue Antigens; 2003 Oct; 62(4):285-95. PubMed ID: 12974795
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Clonal diversity of the T-cell population responding to a dominant HLA-A2 epitope of HER-2/neu after active immunization in an ovarian cancer patient.
    Knutson KL; Disis ML
    Hum Immunol; 2002 Jul; 63(7):547-57. PubMed ID: 12072190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.